Literature DB >> 11095775

Trials of the Use of Antimicrobial Agents in Cardiovascular Diseases.

.   

Abstract

Entities:  

Year:  1999        PMID： 11095775     DOI： 10.1007/s11908-996-0016-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  8 in total

1.  Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.

Authors:  D J Sexton; M J Tenenbaum; W R Wilson; J M Steckelberg; A D Tice; D Gilbert; W Dismukes; R H Drew; D T Durack
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

2.  Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children?

Authors:  J A Stockheim; E G Chadwick; S Kessler; M Amer; N Abdel-Haq; A S Dajani; S T Shulman
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Antibiotics for prevention of endocarditis during dentistry: time to scale back?

Authors:  D T Durack
Journal:  Ann Intern Med       Date:  1998-11-15       Impact factor: 25.391

4.  Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis.

Authors:  P E Fournier; J P Casalta; G Habib; T Messana; D Raoult
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

5.  Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study.

Authors:  B L Strom; E Abrutyn; J A Berlin; J L Kinman; R S Feldman; P D Stolley; M E Levison; O M Korzeniowski; D Kaye
Journal:  Ann Intern Med       Date:  1998-11-15       Impact factor: 25.391

6.  Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients.

Authors:  K A Marr; L Kong; V G Fowler; A Gopal; D J Sexton; P J Conlon; G R Corey
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

7.  Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.

Authors:  Y S Kim; Q Liu; L L Chow; H F Chambers; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

8.  Oral antibiotic therapy in infective endocarditis.

Authors:  R E Fuller; S L Hayward
Journal:  Ann Pharmacother       Date:  1996-06       Impact factor: 3.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.